The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Neurodegenerative disease: models, mechanisms, and a new hope
Open accessAbstract
Neurodegeneration is a feature of many debilitating, incurable diseases that are rapidly rising in prevalence, such as Parkinson's disease. There is an urgent need to develop new and more effective therapeutic strategies to combat these devastating diseases. Models – from cell-based systems, to unicellular organisms, to complex animals – have proven to be a useful tool to help the research community shed light on the mechanisms underlying neurodegenerative diseases, and these advances have now begun to provide promising therapeutic avenues. In this themed issue of Disease Models & Mechanisms, a special collection of articles focused on neurodegenerative diseases is introduced. The collection includes original research articles that provide new insights into the complex pathophysiology of such diseases, revealing candidate biomarkers or therapeutic targets. Some of the articles describe a new disease model that enables deeper exploration of key mechanisms. We also present a series of reviews that highlight some of the recent translational advances made in studies of neurodegenerative diseases. In this Editorial, we summarize the articles featured in this collection, emphasizing the impact that model-based studies have made in this exciting area of research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Polazzi, E., Mengoni, I., Caprini, M., Peña-Altamira, E., Kurtys, E., & Monti, B. (2013) · Neurosignals · doi:10.1159/000337115 · Cited by 8,994
Decoding ALS: from genes to mechanism
Taylor, J. P., Brown, R. H., & Cleveland, D. W. (2016) · Nature · doi:10.1038/nature20413 · Cited by 2,066
Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia
Boillée, S., Yamanaka, K., Lobsiger, C. S., Copeland, N. G., Jenkins, N. A., Kassiotis, G., Kollias, G., & Cleveland, D. W. (2006) · Science · doi:10.1126/science.1123511 · Cited by 1,623
Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture
Paşca, A. M., Sloan, S. A., Clarke, L. E., Tian, Y., Makinson, C. D., Huber, N., Kim, C. H., Park, J.-Y., O'Rourke, N. A., Nguyen, K. D., et al. (2015) · Nature Methods · doi:10.1038/nmeth.3415 · Cited by 1,609
α-Synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson's Models
Cooper, A. A., Gitler, A. D., Cashikar, A., Haynes, C. M., Hill, K. J., Bhullar, B., Liu, K., Xu, K., Strathearn, K. E., Liu, F., et al. (2006) · Science · doi:10.1126/science.1129462 · Cited by 1,376
Self-citationAtaxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS
Elden, A. C., Kim, H.-J., Hart, M. P., Chen-Plotkin, A. S., Johnson, B. S., Fang, X., Armakola, M., Geser, F., Greene, R., Lu, M. M., et al. (2010) · Nature · doi:10.1038/nature09320 · Cited by 1,325
Self-citationAggregation and Motor Neuron Toxicity of an ALS-Linked SOD1 Mutant Independent from Wild-Type SOD1
Bruijn, L. I., Houseweart, M. K., Kato, S., Anderson, K. L., Anderson, S. D., Ohama, E., Reaume, A. G., Scott, R. W., & Cleveland, D. W. (1998) · Science · doi:10.1126/science.281.5384.1851 · Cited by 1,228
Chaperone Suppression of α-Synuclein Toxicity in a Drosophila Model for Parkinson's Disease
Auluck, P. K., Chan, H. Y. E., Trojanowski, J. Q., Lee, V. M.-Y., & Bonini, N. M. (2002) · Science · doi:10.1126/science.1067389 · Cited by 1,227 · cited 1×
“…key insights into disease mechanisms (Link, 1995; Krobitsch and Lindquist, 2000; Boillee et al., 2006; Bruijn et al., 1998; Yamamoto et al., 2000; Auluck et al., 2002; Outeiro and Lindquist, 2003; Cooper et al., 2006; Gitler et al., 2008, 2009; Elden et al., 2010; Couthouis et al., 2011;…”
BackgroundAgeing, neurodegeneration and brain rejuvenation
Wyss-Coray, T. (2016) · Nature · doi:10.1038/nature20411 · Cited by 1,147
Reversal of Neuropathology and Motor Dysfunction in a Conditional Model of Huntington's Disease
Yamamoto, A., Lucas, J. J., & Hen, R. (2000) · Cell · doi:10.1016/s0092-8674(00)80623-6 · Cited by 1,067
Finkel, R. S., Chiriboga, C. A., Vajsar, J., Day, J. W., Montes, J., De Vivo, D. C., Yamashita, M., Rigo, F., Hung, G., Schneider, E., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31408-8 · Cited by 1,019
Non–cell autonomous toxicity in neurodegenerative disorders: ALS and beyond
Ilieva, H., Polymenidou, M., & Cleveland, D. W. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200908164 · Cited by 1,008
Yeast Cells Provide Insight into Alpha-Synuclein Biology and Pathobiology
Outeiro, T. F., & Lindquist, S. (2003) · Science · doi:10.1126/science.1090439 · Cited by 806
Hua, Y., Sahashi, K., Rigo, F., Hung, G., Horev, G., Bennett, C. F., & Krainer, A. R. (2011) · Nature · doi:10.1038/nature10485 · Cited by 741
Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans.
Link, C. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9368 · Cited by 687
Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model
Hua, Y., Sahashi, K., Hung, G., Rigo, F., Passini, M. A., Bennett, C. F., & Krainer, A. R. (2010) · Genes & Development · doi:10.1101/gad.1941310 · Cited by 664
Jovičić, A., Mertens, J., Boeynaems, S., Bogaert, E., Chai, N., Yamada, S. B., Paul, J. W., Sun, S., Herdy, J. R., Bieri, G., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4085 · Cited by 598
Self-citationTherapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice
Becker, L. A., Huang, B., Bieri, G., Ma, R., Knowles, D. A., Jafar-Nejad, P., Messing, J., Kim, H. J., Soriano, A., Auburger, G., et al. (2017) · Nature · doi:10.1038/nature22038 · Cited by 571
Self-citationThe road to restoring neural circuits for the treatment of Alzheimer's disease
Canter, R. G., Penney, J., & Tsai, L.-H. (2016) · Nature · doi:10.1038/nature20412 · Cited by 565
Krobitsch, S., & Lindquist, S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1589 · Cited by 542
Gitler, A. D., Chesi, A., Geddie, M. L., Strathearn, K. E., Hamamichi, S., Hill, K. J., Caldwell, K. A., Caldwell, G. A., Cooper, A. A., Rochet, J.-C., et al. (2009) · Nature Genetics · doi:10.1038/ng.300 · Cited by 535
Self-citationThe Parkinson's disease protein α-synuclein disrupts cellular Rab homeostasis
Gitler, A. D., Bevis, B. J., Shorter, J., Strathearn, K. E., Hamamichi, S., Su, L. J., Caldwell, K. A., Caldwell, G. A., Rochet, J.-C., McCaffery, J. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710685105 · Cited by 523
Self-citationDefects in trafficking bridge Parkinson’s disease pathology and genetics
Abeliovich, A., & Gitler, A. D. (2016) · Nature · doi:10.1038/nature20414 · Cited by 462
Self-citationHeemels, M.-T. (2016) · Nature · doi:10.1038/539179a · Cited by 407
A yeast functional screen predicts new candidate ALS disease genes
Couthouis, J., Hart, M. P., Shorter, J., DeJesus-Hernandez, M., Erion, R., Oristano, R., Liu, A. X., Ramos, D., Jethava, N., Hosangadi, D., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109434108 · Cited by 389
Self-citationMechanisms of protein-folding diseases at a glance
Valastyan, J. S., & Lindquist, S. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.013474 · Cited by 307
Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease models
Armakola, M., Higgins, M. J., Figley, M. D., Barmada, S. J., Scarborough, E. A., Diaz, Z., Fang, X., Shorter, J., Krogan, N. J., Finkbeiner, S., et al. (2012) · Nature Genetics · doi:10.1038/ng.2434 · Cited by 258
Self-citationModelling amyotrophic lateral sclerosis: progress and possibilities
Van Damme, P., Robberecht, W., & Van Den Bosch, L. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.029058 · Cited by 204
The role of Ca2+ signaling in Parkinson's disease
Zaichick, S. V., McGrath, K. M., & Caraveo, G. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.028738 · Cited by 188
Constructing and Deconstructing Stem Cell Models of Neurological Disease
Han, S. S. W., Williams, L. A., & Eggan, K. C. (2011) · Neuron · doi:10.1016/j.neuron.2011.05.003 · Cited by 159
RNA metabolism in neurodegenerative disease
Liu, E. Y., Cali, C. P., & Lee, E. B. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.028613 · Cited by 142
Fishing for causes and cures of motor neuron disorders
Patten, S. A., Armstrong, G. A. B., Lissouba, A., Kabashi, E., Parker, J. A., & Drapeau, P. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.015719 · Cited by 70
Fernández-Trapero, M., Espejo‐Porras, F., Rodríguez‐Cueto, C., Coates, J. R., Pérez-Díaz, C., de Lago, E., & Fernández‐Ruíz, J. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.028373 · Cited by 65
Immortalized Parkinson's disease lymphocytes have enhanced mitochondrial respiratory activity
Annesley, S. J., Lay, S. T., Piazza, S. W. D., Sanislav, O., Hammersley, E., Allan, C. Y., Francione, L. M., Bui, M., Chen, Z.-P., Ngoei, K. R. W., et al. (2016) · Disease Models & Mechanisms · doi:10.1242/dmm.025684 · Cited by 57
Cho, K., Yoon, D., Qiu, S., Danziger, Z. C., Grill, W. M., Wetsel, W. C., & Ferreira, P. A. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.027730 · Cited by 42
Neural Differentiation in the Third Dimension: Generating a Human Midbrain
Marton, R. M., & Pașca, S. P. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.07.017 · Cited by 35
Chaverra, M. E., George, L., Mergy, M. A., Waller, H. R., Kujawa, K. J., Murnion, C., Sharples, E., Thorne, J., Podgajny, N., Grindeland, A., et al. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.028258 · Cited by 35
Westbroek, W., Nguyen, M. H., Siebert, M., Lindstrom, T., Burnett, R. A., Aflaki, E., Jung, O., Tamargo, R. J., Rodriguez‐Gil, J. L., Acosta, W. L., et al. (2016) · Disease Models & Mechanisms · doi:10.1242/dmm.024588 · Cited by 27
Baldassarro, V. A., Marchesini, A., Giardino, L., & Calzà, L. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.028001 · Cited by 27
Lahut, S., Gispert, S., Ömür, Ö., Depboylu, C., Seidel, K., Domínguez-Bautista, J. A., Brehm, N., Tireli, H., Hackmann, K., Cetinkaya, C. P., et al. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.028035 · Cited by 23
Rodella, U., Negro, S., Scorzeto, M., Bergamin, E., Jalink, K., Montecucco, C., Yuki, N., & Rigoni, M. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.027870 · Cited by 20
Kim, D. Y., Yu, J., Mui, R. K., Niibori, R., Taufique, H. B., Aslam, R., Semple, J. W., & Cordes, S. P. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.027433 · Cited by 17
Wald-Altman, S., Pichinuk, E., Kakhlon, O., & Weil, M. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.027938 · Cited by 5
Susan Lindquist: Visionary scientist and peerless mentor
Bevis, B. J. (2016) · The Journal of Cell Biology · doi:10.1083/jcb.201612112 · Cited by 3
From Yeast to Patients: The Audacity and Vision of Susan Lindquist
Khurana, V., Chung, C. Y., & Tardiff, D. F. (2017) · Cell Systems · doi:10.1016/j.cels.2017.02.007 · Cited by 3
Siegel, V. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.028696 · Cited by 2
Cited by
Artificial intelligence to deep learning: machine intelligence approach for drug discovery
Gupta, R., Srivastava, D., Sahu, M., Tiwari, S., Ambasta, R. K., & Kumar, P. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10217-3 · Cited by 1,473
“Further, these disorders can exhibit varying symptoms like cognitive decline, slow movement, tremors, memory loss, depression, speaking problems, muscle stiffness [460, 461].”
BackgroundPhase separation and neurodegenerative diseases: a disturbance in the force
Zbinden, A., Pérez-Berlanga, M., De Rossi, P., & Polymenidou, M. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.09.014 · Cited by 500
Rutin as a Potent Antioxidant: Implications for Neurodegenerative Disorders
Enogieru, A. B., Haylett, W., Hiss, D. C., Bardien, S., & Ekpo, O. E. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/6241017 · Cited by 476
Redox Signaling by Reactive Electrophiles and Oxidants
Parvez, S., Long, M. J. C., Poganik, J. R., & Aye, Y. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00698 · Cited by 359
Biomedical Applications and Bioavailability of Curcumin—An Updated Overview
Sohn, S.-I., Priya, A., Balasubramaniam, B., Muthuramalingam, P., Sivasankar, C., Selvaraj, A., Valliammai, A., Jothi, R., & Pandian, S. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122102 · Cited by 305
Metadata
- Authors
- Gitler, A. D., Dhillon, P., & Shorter, J.
- Venue
- Disease Models & Mechanisms
- Publisher
- The Company of Biologists
- Published
- 2017-05-01
- Volume
- 10
- Issue
- 5
- Pages
- 499-502
- ISSN
- 1754-8403 (ISSN-L)
- 1754-8411
- OpenAlex
- W2611631440
- Cited by
- 739
- References
- 46
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.